On August 18, 2015, the FDA proudly announced that they had approved (after 2 previous rejections) a new drug whose generic name is flibanserin (Addyi will be the brand name when it comes to your local drug store in mid-October). The only drug that Sprout Pharmaceuticals has ever marketed, flibanserin is purported to treat a “disease” called hypoactive sexual desire disorder …
Ask Beatty – 08.24.15
Beatty talked about the 10 areas that need to be explored BEFORE even thinking about taking the new FDA drug, Flibanserin or Addyi for women with low libido. Her insights about sexuality can make or break your sex life!